Argonautica Private Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$734K Buy
5,715
+9
+0.2% +$1.05K 0.18% 97
2026
Q1
$686K Buy
5,706
+78
+1% +$9.01K 0.21% 99
2025
Q4
$592K Hold
5,628
– – 0.17% 115
2025
Q3
$472K Buy
5,628
+31
+0.6% +$2.55K 0.14% 125
2025
Q2
$443K Hold
5,597
– – 0.14% 127
2025
Q1
$502K Hold
5,597
– – 0.17% 108
2024
Q4
$557K Hold
5,597
– – 0.18% 107
2024
Q3
$636K Hold
5,597
– – 0.21% 94
2024
Q2
$693K Hold
5,597
– – 0.24% 92
2024
Q1
$739K Buy
+5,597
New +$690K 0.26% 83

Other funds holding MRK

Argonautica Private Wealth Management's MRK Position: Q2 2026 in Review

Argonautica Private Wealth Management increased its Merck (MRK) stake by 0.16% in Q2 2026, buying an estimated $1.05K and bringing the position to 5,715 shares worth $734K. The position accounts for 0.18% of the portfolio, ranked #97.

Argonautica Private Wealth Management first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. The position peaked at $739K in Q1 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Argonautica Private Wealth Management held 5,715 shares of Merck worth $734K as of Q2 2026.
  • Argonautica Private Wealth Management bought 9 Merck shares in Q2 2026, an estimated $1.05K.
  • Merck made up 0.18% of Argonautica Private Wealth Management's portfolio in Q2 2026, its #97 holding.
  • Argonautica Private Wealth Management first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • Argonautica Private Wealth Management's Merck position peaked at $739K in Q1 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Argonautica Private Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.